منابع مشابه
Radiotherapy techniques for intracranial tumours
ABSTRACTIntracranial tumours often require radiotherapeutic approaches that differ from other sites. Their specific requirements merit a specialized discussion. A brief review of radiotherapy techniques to treat intracranial tumours is presented with emphasis on the author’s own experience and work, where appropriate. A clinical introduction is presented first followed by a description of bot...
متن کاملRisk factors for recurrence of giant cell tumours of bone.
PURPOSE To determine the risk factors for recurrence of giant cell tumours (GCTs) of bone. METHODS Medical records of 29 men and 29 women (mean age, 34 years) treated for primary (n=53) or recurrent (n=5) GCTs of bone and followed up for a mean of 40.2 months were reviewed. The tumours were located in the distal femur (n=18), proximal tibia (n=10), proximal femur (n=8), distal radius (n=7), p...
متن کاملGrowth impairment in children treated for brain tumours.
Growth and growth hormone (GH) secretion were studied in 14 children with brain tumours before radiation and chemotherapy and at various time intervals afterwards. The peak GH response to hypoglycaemia was normal in all patients before radiation. In 6 patients the peak GH response was impaired 1 year after radiation, and in a seventh it was normal at 1 year but impaired 2 years after radiation....
متن کاملBreed and Age as Risk Factors for Canine Mammary Tumours
Zatloukal J . , J . Lorenzová, F. Tich ̆, A. Neãas, H. Kecová, P. Kohout: Breed and Age as Risk Factors for Canine Mammary Tumours. Acta Vet. Brno 2005, 74: 103-109. Mammary tumours in 214 dogs were evaluated at the Department of Surgery and Orthopaedics, Veterinary and Pharmaceutical University Brno, between 1997 and 2001. Lesions of the mammary gland were classified as dysplasia/hyperplasia, b...
متن کاملOncogenes, growth factors, receptor expression and proliferation markers in digestive neuroendocrine tumours. A critical reappraisal.
BACKGROUND The main characteristic of the digestive neuroendocrine tumours (dNETs) is the low proliferating activity, even in the presence of malignant, metastatic behavior. PATIENTS AND METHODS Considering that dNETs are rare diseases, relatively numerous studies, often including a conspicuous number of patients, have recently investigated the molecular mechanisms of neuroendocrine tumour ge...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature
سال: 1978
ISSN: 0028-0836,1476-4687
DOI: 10.1038/272670a0